Spectrum of 18F-FDG Uptake in Bilateral Lung Parenchymal Diseases on PET/CT
Authors:
- 13 September 2019
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 45 (1) , e15-e19
Abstract
Bilateral lung parenchymal involvement is seen in infective as well as noninfective conditions, appearing as focal or diffuse lung disease. PET/CT with FDG helps in characterization (increased glucose utilization is seen by both inflammatory and neoplastic cells). In this article, we describe the spectrum of patterns of FDG uptake and associated CT changes involving bilateral lung parenchyma. Benign conditions described are aspiration pneumonia; pulmonary toxicity by bleomycin; infections, namely, sarcoidosis, miliary pulmonary tuberculosis, and pulmonary nocardiosis; and inflammatory conditions such as pulmonary Langerhans cell histiocytosis and pulmonary alveolar proteinosis. Neoplastic conditions described are bilateral pulmonary metastases and lymphangitic carcinomatosis.Keywords
This publication has 8 references indexed in Scilit:
- Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosisJapanese Journal of Radiology, 2017
- Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospitalExperimental and Therapeutic Medicine, 2014
- FDG PET Imaging in SarcoidosisSeminars in Nuclear Medicine, 2013
- F-18 FDG PET/CT in Pulmonary Alveolar ProteinosisClinical Nuclear Medicine, 2009
- Pictorial essay: PET/CT in tuberculosisIndian Journal of Radiology and Imaging, 2008
- Pulmonary Drug Toxicity: Radiologic and Pathologic ManifestationsRadioGraphics, 2000
- Aspiration Diseases: Findings, Pitfalls, and Differential DiagnosisRadioGraphics, 2000
- CT findings in lymphangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests.American Journal of Roentgenology, 1992